Galantamine Extended-Release Capsules and Golimumab Subcutaneous
Determining the interaction of Galantamine Extended-Release Capsules and Golimumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: galantamine
Brand name: Razadyne, Razadyne ER, Reminyl
Synonyms: Galantamine
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Galantamine Extended-Release Capsules-GoLYTELY
- Galantamine Extended-Release Capsules-Gonadorelin
- Galantamine Extended-Release Capsules-Gonadorelin Intravenous, Injection
- Galantamine Extended-Release Capsules-Gonadotropin, Chorionic
- Galantamine Extended-Release Capsules-Gonal-F
- Galantamine Extended-Release Capsules-Gonal-f RFF
- Golimumab Subcutaneous-Galantamine Hydrobromide
- Golimumab Subcutaneous-Galantamine Oral Solution
- Golimumab Subcutaneous-Galantamine Solution
- Golimumab Subcutaneous-Galantamine Tablets
- Golimumab Subcutaneous-Gallium
- Golimumab Subcutaneous-Gallium citrate ga 67 Intravenous